{"id":"W4391883120","doi":"10.1038/s41591-023-02794-7","title":"Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial","year":2024,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer","keywords":"Medicine; Placebo; Hemodialysis; Adverse effect; Randomized controlled trial; Clinical endpoint; Population; Internal medicine; Incidence (geometry); Kidney disease; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007492353,0.0003615093,0.001229543,0.0005646384,0.00008108403,0.0000404751,0.00008491244,0.0003426684,0.0002530502],"category_scores_gemma":[0.00103094,0.0002053289,0.0001511711,0.001158628,0.0002446758,0.0002309857,0.00001658456,0.0007300712,0.000008510311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001445847,"about_ca_system_score_gemma":0.0004744719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005897116,"about_ca_topic_score_gemma":0.00008502996,"domain_scores_codex":[0.997396,0.0001370577,0.0006074364,0.0005486155,0.0009604018,0.0003504823],"domain_scores_gemma":[0.9984786,0.0005660674,0.000163504,0.0003204737,0.0002143597,0.000257026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9566226,0.001027735,0.01943493,0.0007484616,0.001180202,0.000254021,0.003068492,0.00003235448,0.00020672,0.00209487,0.006840375,0.008489267],"study_design_scores_gemma":[0.9802814,0.002312414,0.005489884,0.00394088,0.001664365,0.00002242834,0.0001621961,0.002558012,0.0001966579,0.0003293331,0.00274348,0.0002989435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733669,0.004782119,0.001434196,0.01535382,0.0007807518,0.002990592,0.00001353644,0.0002623838,0.001015759],"genre_scores_gemma":[0.9956391,0.00005598289,0.0006487808,0.001298579,0.001074487,0.000061531,0.0007162575,0.00006133302,0.0004438998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02365883,"threshold_uncertainty_score":0.8373071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006392928085725645,"score_gpt":0.2765367744672467,"score_spread":0.2701438463815211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}